Clinical Trial Update: CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease [Phase 1, Phase 2]

View source ↗

Summary

Miltenyi Biomedicine is conducting Phase 1/2 trials of CAR-T cell therapy targeting B cells for autoimmune diseases, including systemic lupus erythematosus, sys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Miltenyi Biomedicine GmbH | Conditions: Systemic Lupus Erythematosus, Systemic Sclerosis | Phase 1, Phase 2 | Status: RECRUITING